Expiration date: 08/2026

Nicergoline improves cerebral blood circulation, activates the metabolism of the brain. It reduces the resistance vessels of the brain, increases arterial blood flow and oxygen consumption and glucose brain tissue.

Product: tablets, coated tablets, 10 mg. At 10, 15, 20 or 30 tablets in blisters of PVC film and aluminum foil printed patent.

At 1, 2, 3 or 5, the contour of cellular packaging with instructions for use in a pile of cardboard

Ingredients: nicergoline - 0.0100 g

Indications: Acute and chronic cerebral metabolic and vascular disorders (due to atherosclerosis, hypertension, thrombosis and cerebral embolism), including transient ischemic attack, vascular dementia, and headache caused by vasospasm.

Acute and chronic (metabolic and vascular) peripheral disorders (organic and functional arteriopathy, Raynaud's disease, syndromes, peripheral blood flow caused by a violation).

Dosage and administration:

Inside, 10 mg three times a day at regular intervals between doses for a long period of time (several months).

In vascular dementia shows the use of 30 mg 2 times a day, at the same time every 6 months is recommended to consult with your doctor about whether to continue therapy.

The dose and duration of treatment depends on the nature, severity of disease and the effectiveness of treatment. In some cases it is preferable to start therapy with parenteral administration, and then go to the ingestion of the drug for the maintenance treatment.

If the kidney function (serum creatinine ? 2 mg / dL) preparation is recommended for lower therapeutic doses.